Jason Nalewany has been appointed as Chief Financial Officer of MTL Cannabis.

Mr. Nalewany brings over 18 years of financial expertise, having held pivotal roles in capital market strategies, fundraising, M&A advisory, and go-public mandates. He has previously held the CFO role at Montreal Cannabis Medical Inc., in addition to previously holding senior finance roles at MediPharm Labs, where he helped support the initial development of the company and drive more than $129M of sales and $29M EBITDA in its first full year of operations, and Aurora Cannabis Inc., where he played a significant role in Aurora's $3.2 billion merger with MedReleaf Corp. His extensive experience also includes strategic roles at Methanex Corporation, FTI Consulting Inc., and MNP LLP. Mr. Nalewany began his career in the audit and assurance practice at PricewaterhouseCoopers LLP, Canada. He is a Canadian Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Victoria.

"Jason has been a key part of MTL over the past two years, specifically operating as the driving force to help complete the RTO transaction this past summer." Commented Michael Perron, CEO of MTL Cannabis Corp. "Jason brings incredible experience and demonstrated excellence to the CFO position. We look forward to continuing to build the company with Jason leading our finance team."

Mr. Nalewany will be replacing Peili Miao, who previously held the position at MTL Cannabis Corp.

"Peili has agreed to assist the Company with the CFO transition, and we thank her for her continued contributions and wish her the best on her future endeavours." Commented Michael Perron.

For more information:
MTL Cannabis
mtlcannabis.ca